Search

Srinivas N Pentyala

from South Setauket, NY
Age ~59
Get Report
Also known as:
Srinivas Dr Pentyala, Srinivas D Pentyala, Srinivas A
Phone and address:
21 Sunflower Ridge Rd, South Setauket, NY 11720
(631) 585-5732
Related to:
Pranav KumarRamirez M Kumar, 68Srikanth PentyalaSridhar Pentyala, 56Sahana Pentyala, 58Arun M Kumar, 68Sudha R Pentyala, 57Sujanasri Pentyala, 51
Connected to:
Candy S Pentz, 73Christine Pentz, 56Donald C Pentz, 85Joseph L Pentz, 68Karen L Pentz, 71Lundy H Pentz, 73Melissa Pentz, 43Mike J Pentz, 69Charles F Pentzer, 66Scott G Pentzer, 45

Srinivas Pentyala Phones & Addresses

  • 21 Sunflower Ridge Rd, Centereach, NY 11720 (631) 585-5732 (631) 981-1794
  • 28 Ulrich Rd, Centereach, NY 11720 (631) 981-2302
  • South Setauket, NY
  • Commack, NY
  • Jackson, MS
  • Port Jefferson, NY

Publications

Us Patents

Methods, Antibodies And Kits For Detecting Cerebrospinal Fluid In A Sample

View page
US Patent:
8003765, Aug 23, 2011
Filed:
Apr 14, 2008
Appl. No.:
12/102091
Inventors:
Srinivas N. Pentyala - South Setauket NY, US
Assignee:
Stony Brook Anaesthesiology, University Faculty Practice Corporation - Stony Brook NY
International Classification:
C07K 16/40
G01N 33/573
G01N 33/00
G01N 33/53
C12M 1/34
C12N 5/12
US Classification:
5303881, 435 74, 435 794, 4352872, 4352877, 4352879, 435331, 420430
Abstract:
The present disclosure relates to detection of the presence or absence of cerebrospinal fluid (CSF) in a sample, in particular to the analysis of the CSF protein lipocalin-type prostaglandin D2 synthase (L-PGDS). The present disclosure provides assays for the analysis of L-PGDS indicating the presence or absence of CSF in a sample.

Methods And Kits For Detecting Cerebrospinal Fluid In A Sample

View page
US Patent:
20070003992, Jan 4, 2007
Filed:
Sep 6, 2006
Appl. No.:
11/516385
Inventors:
Srinivas Pentyala - South Setauket NY, US
International Classification:
G01N 33/53
C12M 3/00
US Classification:
435007920, 435287200, 977900000
Abstract:
The present invention relates to detection of the presence or absence of cerebrospinal fluid (CSF) in a sample, in particular to the analysis of the CSF protein lipocalin-type prostaglandin D2 synthase (L-PGDS). The present invention provides assays for the analysis of PGDS indicating the presence or absence of CSF in a sample.

Method And Kits For Detecting Cerebrospinal Fluid In A Sample

View page
US Patent:
20070196864, Aug 23, 2007
Filed:
Apr 26, 2007
Appl. No.:
11/789868
Inventors:
Srinivas Pentyala - South Setauket NY, US
International Classification:
G01N 33/53
G01N 33/558
US Classification:
435007100, 436514000, 977902000
Abstract:
The present invention relates to detection of the presence or absence of cerebrospinal fluid (CSF) in a sample, in particular to the analysis of the CSF protein lipocalin-type prostaglandin D2 synthase (L-PGDS). The present invention provides assays for the analysis of PGDS indicating the presence or absence of CSF in a sample.

Gdnf-Derived Peptides

View page
US Patent:
20090069230, Mar 12, 2009
Filed:
Feb 12, 2008
Appl. No.:
12/030172
Inventors:
Srinivas N. Pentyala - South Setauket NY, US
John D. Glass - Shoreham NY, US
Assignee:
The Research Foundation of State University of New York - Stony Brook NY
International Classification:
A61K 38/22
C07K 14/575
C07H 21/04
C12N 15/64
C12N 5/10
A61P 25/28
US Classification:
514 12, 530324, 536 2351, 4353201, 435366
Abstract:
Compositions that include peptides derived from glial-derived neurotrophic factor (GDNF) (e.g., substantially pure polypeptides comprising a fragment of a GDNF precursor protein) and biologically active variants thereof are provided. The compositions can include one or more types of peptides and can include other substances (e.g., pharmaceutically acceptable carriers or diluents or liposomes). Also provided are methods for using the compositions for treatment of neurological disorders (e.g., motor system disorders and sensory system disorders).

Polypeptides Derived From Calcitonin Receptors And Methods Of Use

View page
US Patent:
20130345138, Dec 26, 2013
Filed:
Dec 7, 2011
Appl. No.:
13/992005
Inventors:
Srinivas Pentyala - South Setauket NY, US
Assignee:
The Research Foundation of State University of New York - Albany NY
International Classification:
C07K 14/72
US Classification:
514 169, 530300, 530327, 530326, 530328, 536 235, 4353201, 43525233, 435348, 4352542, 435325
Abstract:
The present invention is based, in part, on our discovery of compositions and methods that can be used to treat a patient who has a compromised bone (due, for example, to a disease such as osteoporosis or an injury such as a bone fracture). The compositions can also be administered prophylactically. For example, they can be administered to help maintain bone health as a patient ages. More specifically, the compositions include polypeptides that constitute (or that include) a fragment of a calcitonin receptor (CR) and polypeptides that constitute (or include) biologically active variants of those fragments. Sequence-specific formulas are provided herein, and polypeptides conforming to those formulas, as well as nucleic acids encoding them, expression vectors, host cells, pharmaceutical formulations, and methods of their preparation and use are within the scope of the present invention.

Polypeptides Derived From Calcitonin Receptors And Methods Of Use

View page
US Patent:
20170190760, Jul 6, 2017
Filed:
Nov 10, 2016
Appl. No.:
15/347931
Inventors:
- Albany NY, US
Srinivas Pentyala - South Setauket NY, US
International Classification:
C07K 14/72
Abstract:
The present invention is based, in part, on our discovery of compositions and methods that can be used to treat a patient who has a compromised bone (due, for example, to a disease such as osteoporosis or an injury such as a bone fracture). The compositions can also be administered prophylactically. For example, they can be administered to help maintain bone health as a patient ages. More specifically, the compositions include polypeptides that constitute (or that include) a fragment of a calcitonin receptor (CR) and polypeptides that constitute (or include) biologically active variants of those fragments. Sequence-specific formulas are provided herein. Related U.S. Application Data and polypeptides conforming to those formulas, as well as nucleic acids encoding them, expression vectors, host cells, pharmaceutical formulations, and methods of their preparation and use are within the scope of the present invention.
Control profile
Srinivas N Pentyala from South Setauket, NY, age ~59 Get Report